Read + Share
Amedeo Smart
Independent Medical Education
Nauck MA, Quast DR, Wefers J, Pfeiffer AFH, et al. The evolving story of incretins (GIP and GLP-1) in metabolic and cardiovascular disease: A pathophysiological update. Diabetes Obes Metab 2021;23 Suppl 3:5-29.PMID: 34310013
Email
LinkedIn
Facebook
Twitter
Privacy Policy